Rxo (RXO) Short term Debt (2022 - 2026)

Rxo (RXO) has reported Short term Debt for 5 consecutive years, with $17.0 million the latest figure, recorded in Q1 2026.

• Short term Debt for Q1 2026 came in at $17.0 million, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.0 million (changed 0.0% YoY), and the FY2025 annual result was $17.0 million, changed 0.0% from the prior year.
• Short term Debt was $17.0 million for Q1 2026 at Rxo, roughly flat from $17.0 million in the prior quarter.
• Over five years, Short term Debt peaked at $17.0 million in Q4 2024 and troughed at $3.0 million in Q3 2023.
• Average Short term Debt over 5 years is $11.3 million, with a median of $16.0 million recorded in 2024.
• Year-over-year, Short term Debt slumped 40.0% in 2023 and jumped 466.67% in 2024.
• Over 5 years, Short term Debt stood at $4.0 million in 2022, then dropped by 25.0% to $3.0 million in 2023, then surged by 466.67% to $17.0 million in 2024, then changed by 0.0% to $17.0 million in 2025, then changed by 0.0% to $17.0 million in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $17.0 million in Q1 2026, $17.0 million in Q4 2025, and $16.0 million in Q3 2025.